Pretty weak conclusion to this post. Yes, the US spends way more on healthcare (as share of GDP) than any other industrialized nation, but cheaper blood glucose monitoring is not going to put a dent into that price tag. Basically every other nation in the world negotiates prices of medicines and services and has some form of a simpler, single provider model. The US healthcare system is a massive business and there are too many players involved that all siphon profit off at some level, worsening outcomes and inflating prices.